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Abstract 
The main objective of this study was to determine the prevalence of non-albicans Candida among the 
patients attending a tertiary care hospital in Kathmandu, Nepal. Candida spp. isolated from different 
clinical samples (sputum, urine, vaginal swab, blood, endotracheal (ET) secretion, pus) from 250 patients 
between the period of February 2013 and December 2015 were included in the study. Of those 250 
patients, 20% were immunocompromised. Sabouraud dextrose agar was used for the isolation of 
Candida spp. and the identification was performed on the basis of colony morphology, Gram’s stain, 
India ink preparation, germ tube test, temperature tolerance test, characteristic color change in 
CHROMagar, chlamydospore production, sugar fermentation test and sugar assimilation test. 
Out of total 300 Candida spp., majority were isolated from sputum (43.33%) followed by urine (40%) and 
vaginal swab (6.67%). Of total 151 (50.33%) non-albicans Candida, the most common species isolated 
were C. tropicalis (62.25%) followed by C. glabrata (23.84%). High prevalence of non-albicans Candida 
among the patients attending a hospital in Kathmandu, Nepal was noted. 




Incidence of fungal infection has increased 
significantly over the past few years, causing 
considerable morbidity and mortality, mainly 
affecting immunocompromised patients. The 
emergence of fungal infections as the worldwide 
health care problems may be attributed to the 
extensive use of broad spectrum antibiotics and 
immune-suppressive agents, as well as an increase in 
the population of immunocompromised people [1]. 
Candida is one of the commonest fungal pathogens 
and may cause infection in immunocompetent as well 
as immunocompromised person [2]. Due to presence 
of Candida spp. as normal flora of mucosal surfaces, 
they mostly cause endogenous infections [3]. Candida 
albicans is considered as the commonest species of 
Candida responsible for causing various infections [4]. 
But in recent years there have been significant 
increase in infections caused by the species of the 
non-albicans Candida [5]. Only small numbers of 
species among the 150 species of Candida are well 
established as human pathogens [6]. Among them, 
Candida glabrata, Candida parapsilosis and Candida 
tropicalis are non-albicans Candida of increasing 
clinical significance [5]. Most of non-albicans Candida 
like C. glabrata, C. krusei, C. tropicalis and C. 
parapsilosis, which are of clinical significance are 
known to show resistance toward certain commonly 
used antifungal agents [7, 8]. So, for optimizing the 
treatment of the infections caused by Candida spp., it 
is necessary to identify the Candida spp. up to species 
level, even if it is not possible to perform antifungal 
susceptibility testing [9]. Further the isolation of the 
Candida spp. from the clinical samples like sputum, 
urine, vaginal swab etc. does not necessarily suggest 
the infection and clinical correlation or confirmation 
of infection by alternative methods is necessary. 
However, the high rate of isolation of Candida spp. 
from clinical specimens (mainly from debilitated 
patients) suggests the possibility of high rate of 
endogenous infections by these organisms. In Nepal 
there are limited data regarding the rate of isolation 
of non-albicans Candida from different clinical 
specimens. So, in this study we determined the 
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prevalence of non-albicans Candida among the 
patients attending a tertiary care hospital. 
Materials and Methods 
Candida spp. isolated from different clinical samples 
(sputum, urine, vaginal swab, blood, endotracheal 
secretion, pus) from 250 patients between the period 
of February 2013 and December 2015, were included 
in the study. Of those 250 patients, 20% were 
immunocompromised. The clinical specimens were 
collected using standard techniques [10]. For the 
isolation of the Candida spp. the samples were 
inoculated on sabouraud dextrose agar and were 
incubated aerobically at 35oC for 48 hrs. Easily 
emulsifiable, white, opaque, dome or flat shaped 
colonies were subjected to further identification by 
Gram’s stain and India ink preparation. The Candida 
spp. were identified up to species level by using the 
following methods: 
Germ tube test: This test was used for the 
preliminary identification of the Candida albicans. A 
small inoculum of the yeast cells from pure culture 
was suspended in 0.5 ml of sheep serum and was 
incubated at 37oC for three hours. Then a drop of the 
incubated serum was observed under microscope 
using 40X objective. The isolates were identified as 
germ tube producing or germ tube non-producing. 
Temperature tolerance: This test was also used for 
the presumptive identification for Candida albicans. 
The isolates were cultured on sabouraud dextrose 
agar and incubated aerobically at 45°C for 72 hours 
and observed for any growth if present. 
CHROMagar Candida: CHROMagar Candida 
(HiMedia, Mumbai, India) was used for presumptive 
identification of various Candida species. The pure 
culture was seeded into CHROMagar media and 
incubated at 35°C for 48 hours. The media was 
observed for characteristic color change.  
Chlamydospore production: It was used for the 
preliminary confirmatory identification of Candida 
albicans. The isolates were inoculated on corn meal 
agar by slide culture technique and incubated at 25°C 
for 72 hours and observed for chlamydospore 
production using lactophenol cotton blue stain. 
Sugar fermentation test: Six percent solution of 
dextrose, maltose, lactose and sucrose with basal 
media were used for the test. 
Sugar assimilation test: Sugars used for this test were 
glucose, lactose, maltose, sucrose and galactose. 
Ethics statement: Our study was in compliance with 
Helsinki declaration. 
Results 
Between February 2013 and December 2015, 300 
Candida spp. were isolated from various clinical 
samples. Majority of the Candida spp. were isolated 
from sputum (43.33%) followed by urine (40%) and 
vaginal swab (6.67%) (Figure 1). 
 














Table 1: Candida spp. isolated from different clinical samples. 
Candida spp. Sputum Urine Vaginal 
swab 
ET secretion Blood Pus Total 
C. albicans 65 56 10 8 6 4 149 
C. tropicalis 43 40 6 2 2 1 94 
C. glabrata 10 16 3 5 2 _ 36 
C. kefyr 7 6 _ _ _ _ 13 
C. krusei 3 _ 1 _ _ _ 4 
C. dubliniensis 2 2 _ _ _ _ 4 
Total 130 120 20 15 10 5 300 
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Among total 300 Candida spp. isolated, 149 (49.67%) 
were Candida albicans and 151 (50.33%) were non-
albicans Candida. Out of 151 non-albicans Candida 
spp., C. tropicalis (62.25%) was the most common non-
albicans Candida followed by C. glabrata (23.84%) 
(Table 1). 
Discussion 
In spite of their ubiquitous presence, only a few fungi 
are considered pathogenic. Skin, nail and hair are the 
commonest sites of fungal infections. But recently 
there have been increased numbers of systemic fungal 
infections due to the use of broad spectrum 
antibiotics, increase in the numbers of 
immunocompromised persons (due to conditions like 
lymphomas, leukemia, organ transplantation, human 
immunodeficiency virus (HIV) infection and use of 
immunosuppressive drugs) [11]. Among the fungal 
pathogens, Candida is a leading cause of a variety of 
human infections [2]. 
In our study the rate of isolation of non-albicans 
Candida (among all Candida spp.) was > 50%; which 
was in accordance to the result reported by 
Deorukhkar et al. (63.3%) [2]. In the present study, 
among total 130 Candida spp. isolated from sputum, 
the rate of isolation of C. albicans was 50% followed 
by C. tropicalis (33.076%) and C. glabrata (7.69%). 
Similar to our observation, in a study by Jha et al., the 
commonest species of Candida isolated from sputum 
was found to be C. albicans (70%) followed by Candida 
tropicalis (13.33%) [3]. However, the isolation of the 
Candida spp. from sputum in our study did not 
necessarily suggest the infection and clinical 
correlation or confirmation of infection by alternative 
method was necessary. But the isolation of the 
Candida spp. from the immunocompromised people 
(having predisposing risk factors) suggests the higher 
risk of endogenous infection. The main risk factors 
responsible for increased numbers of respiratory tract 
infections by Candida spp. are smoking, chronic 
obstructive pulmonary disease, tuberculosis, 
malnutrition, malignancy, diabetes mellitus, human 
immunodeficiency virus infection and prolonged use 
of antibiotics [3].  
In urine samples, the majority of Candida spp. isolated 
were C. albicans (46.67%) followed by C. tropicalis 
(33.3%) and C. glabrata (19.2%). Among all Candida 
spp. the rate of isolation of non-albicans Candida from 
urine was 53.33%. Our finding was in accordance 
with the findings of Deorukhkar et al.  [2] and 
Kauffmann [12], in which >50% of the Candida spp. 
isolated from urine samples were non-albicans 
Candida.  Along with the well adaptability of the non-
albicans Candida spp. for urinary tract infection, it is 
more difficult to treat the infection caused by them in 
comparison to that caused by C. albicans [2]. Old age, 
diabetes mellitus, pregnancy and urinary 
catheterization are the predisposing factor for urinary 
tract infection by Candida spp.  
In a study by Helmy, 14 % of the cases of 
vulvovaginal candidiasis were due to non-albicans 
Candida [8] but in our study 50% of the Candida spp. 
isolated from vaginal swab were non-albicans 
Candida. However, in both studies the C. tropicalis 
followed by C. glabrata were the most common 
species of Candida   isolated from vaginal swab. In the 
study done by Deorukhkar et al. the predominant 
Candida spp. responsible for causing vulvovaginal 
candidiasis were found to be C. glabrata followed 
by C. tropicalis [2]. 
Although, the isolation of the Candida spp. from urine 
and vaginal swab does not necessarily suggest the 
infection; the high rate of isolation of these organisms 
from patients having risk factors for infection by 
Candida spp. could not be neglected. In our study 20 
% of the patients were immunocompromised.  
All the patients from whom Candida spp. were 
isolated from endotracheal secretion were from 
intensive care unit and were intubated. And non-
albicans Candida isolated from their endotracheal 
secretion were 43.75% of all the Candida spp. isolated 
from endotracheal secretion. This indicates that the 
intubation is a very important risk factor for 
acquiring yeast infection. 
In our study, 40% of the non-albicans Candida were 
isolated from the cases of candidemia. The 
predominant non-albicans Candida isolated from 
blood were C. glabrata followed C. tropicalis. Among 
all Candida spp., we found C. albicans to be the 
most predominant cause of candidemia. But in 
the study by Deorukhkar et al. C. glabrata was the 
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commonest species isolated from the cases of 
candidemia [2]. Despite the isolation of C. glabrata 
(mortality rate due to infection by which is higher) 
from only 20% of the cases of the candidemia, in our 
study the mortality rate for the cases of candidemia 
was 80% [2]. 
In our study rate of isolation of Candida spp. was 
higher among patients from intensive care unit and 
those having history of treatment with broad 
spectrum antibiotics (for long period of time). The use 
of broad spectrum antibiotics upsets the balance of 
the normal bacterial flora and results in infection by 
Candida spp.  [2]. Further the patients from intensive 
care unit are debilitated. 
Due to adaptation of the Candida spp. to various 
habitats including medical devices, the incidence of 
hospital acquired infection due to Candida spp. has 
increased [2]. Candida spp. have ability to form 
biofilm and in the study by Deorukhkar et al. the 
biofilm forming capability has been found to be 
higher in C. tropicalis as compared to C. albicans. This 
attribute can help non-albicans Candida like C. 
tropicalis to show higher drug resistance [2]. Further, 
some non-albicans Candida are intrinsically resistant 
to some antifungals mainly in context of 
opportunistic infections in immunocompromised [4]. 
Conclusion 
High prevalence of non-albicans Candida among the 
patients attending a hospital in Kathmandu, Nepal 
was noted. From our study, it can be concluded that 
non-albicans Candida may be of high clinical 
significance mainly in case of the patients with 
predisposing risk factors. 
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